ImmunityBio Reports Third-Quarter 2024 Financial Results

Go back to ImmunityBio Reports Third-Quarter 2024 Financial Results
(NASDAQ: IBRX) Delayed: 8.14 +0.42 (5.44%)
Previous Close $7.72    52 Week High
Open $7.80    52 Week Low
Day High $8.35    P/E N/A 
Day Low $7.80    EPS
Volume 7,713,491